Distigmine
Back to searchMolecule Structure
Scientific Name
Distigmine
Description of the Drug
Distigmine is a cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13694
http://www.drugbank.ca/drugs/DB13694
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16674116 |
| DrugBank | DB13694 |
| PubChem: Thomson Pharma | 16442212 |
| PubChem | 3116 |
| Nikkaji | J221.234J |
| EPA CompTox Dashboard | DTXSID00169484 |
| DrugCentral | 927 |
| rxnorm | DISTIGMINE |
| KEGG Ligand | C16823 |
| ChEBI | 80756 |
| ZINC | ZINC000003872328 |
